Medtronic SenSight Directional DBS lead for depressive disorder, treatment-resistant

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Oct 2023: Trial registered, NCT06096207

The trials

NCT06096207: DBS for Depression

State
Under way
Phase
No phase
People
20 planned
Started
18 Oct 2023
Primary completion
18 Oct 2030
Arms
Discontinuation Phase Group 1, Discontinuation Phase Group 2
Results
None posted
  1. 18 Oct 2023: Trial started
  2. 23 Oct 2023: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.